Replies to post #4143 on Inovio Pharmaceuticals Inc (INO)

[ShadowEEngineer]

Exactly what I'm trying to say:
"I really like this company, and am heavily invested here. My point is that all of the exuberance and talk of a hundred dollar stock needs to be tempered with the reality of the barriers that remain."

Thank you.

[KR_redondo]

I hear what your saying mackwheaton and agree biotech investing is met with many challenges r&d cost,competitors,securing funding and unstable markets..securing funding from big pharma,governments or academic institutions is no easy task and with out that inovio shares will be constantly diluted and the technology would be sold off for cheap to fund the clinical trials process the company is undergoing. Inovio's financial stability lays solely on securing large partnerships. A large pharmaceutical company partnership would be a great boost for ino and possibly help secure future deals with other companies. Anyone pumping that ino doesn't need to partner or ino is going to 100 dollars should hold that mindset for several years, because maybe one day that might be the case..here's an example taken from Inovio's 10-q released may 31st 2013 "the NIAID and VGX Int'l accounted for approximately 69% and 14%, of our consolidated revenue in 2012"..securing funding accounts for a lot concerning ino lets hope the management team is successful in their search of a partner.